Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5825383 | Clinical Therapeutics | 2014 | 6 Pages |
Abstract
Cefpodoxime can be utilized for prophylaxis, without adversely affecting resistance to broad-spectrum agents, and maintains a high level of appropriateness of guideline-recommended empiric regimens. This study of cefpodoxime prophylaxis in adult patients intolerant to fluoroquinolones adds to the literature of potential alternative agents for prophylaxis in neutropenic patients.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Daniel J. PharmD, Jason N. PharmD, Robert C. PharmD, Pritish K. MD,